Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.

Inclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we...

Full description

Bibliographic Details
Main Authors: Paula Castellanos Otero, Tiffany W Todd, Wei Shao, Caroline J Jones, Kexin Huang, Lillian M Daughrity, Mei Yue, Udit Sheth, Tania F Gendron, Mercedes Prudencio, Björn Oskarsson, Dennis W Dickson, Leonard Petrucelli, Yong-Jie Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298080&type=printable
_version_ 1797194874335789056
author Paula Castellanos Otero
Tiffany W Todd
Wei Shao
Caroline J Jones
Kexin Huang
Lillian M Daughrity
Mei Yue
Udit Sheth
Tania F Gendron
Mercedes Prudencio
Björn Oskarsson
Dennis W Dickson
Leonard Petrucelli
Yong-Jie Zhang
author_facet Paula Castellanos Otero
Tiffany W Todd
Wei Shao
Caroline J Jones
Kexin Huang
Lillian M Daughrity
Mei Yue
Udit Sheth
Tania F Gendron
Mercedes Prudencio
Björn Oskarsson
Dennis W Dickson
Leonard Petrucelli
Yong-Jie Zhang
author_sort Paula Castellanos Otero
collection DOAJ
description Inclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we developed rabbit monoclonal antibodies (mAbs) that specifically detect pS409/410-TDP-43 in multiple model systems and FTD/ALS patient samples. Specifically, we identified three mAbs (26H10, 2E9 and 23A1) from spleen B cell clones that exhibit high specificity and sensitivity to pS409/410-TDP-43 peptides in an ELISA assay. Biochemical analyses revealed that pS409/410 of recombinant TDP-43 and of exogenous 25 kDa TDP-43 C-terminal fragments in cultured HEK293T cells are detected by all three mAbs. Moreover, the mAbs detect pS409/410-positive TDP-43 inclusions in the brains of FTD/ALS patients and mouse models of TDP-43 proteinopathy by immunohistochemistry. Our findings indicate that these mAbs are a valuable resource for investigating TDP-43 pathology both in vitro and in vivo.
first_indexed 2024-04-24T06:03:13Z
format Article
id doaj.art-8a84232f980c4c2ab3c974b7c2363957
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-24T06:03:13Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8a84232f980c4c2ab3c974b7c23639572024-04-23T05:31:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01194e029808010.1371/journal.pone.0298080Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.Paula Castellanos OteroTiffany W ToddWei ShaoCaroline J JonesKexin HuangLillian M DaughrityMei YueUdit ShethTania F GendronMercedes PrudencioBjörn OskarssonDennis W DicksonLeonard PetrucelliYong-Jie ZhangInclusions containing TAR DNA binding protein 43 (TDP-43) are a pathological hallmark of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). One of the disease-specific features of TDP-43 inclusions is the aberrant phosphorylation of TDP-43 at serines 409/410 (pS409/410). Here, we developed rabbit monoclonal antibodies (mAbs) that specifically detect pS409/410-TDP-43 in multiple model systems and FTD/ALS patient samples. Specifically, we identified three mAbs (26H10, 2E9 and 23A1) from spleen B cell clones that exhibit high specificity and sensitivity to pS409/410-TDP-43 peptides in an ELISA assay. Biochemical analyses revealed that pS409/410 of recombinant TDP-43 and of exogenous 25 kDa TDP-43 C-terminal fragments in cultured HEK293T cells are detected by all three mAbs. Moreover, the mAbs detect pS409/410-positive TDP-43 inclusions in the brains of FTD/ALS patients and mouse models of TDP-43 proteinopathy by immunohistochemistry. Our findings indicate that these mAbs are a valuable resource for investigating TDP-43 pathology both in vitro and in vivo.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298080&type=printable
spellingShingle Paula Castellanos Otero
Tiffany W Todd
Wei Shao
Caroline J Jones
Kexin Huang
Lillian M Daughrity
Mei Yue
Udit Sheth
Tania F Gendron
Mercedes Prudencio
Björn Oskarsson
Dennis W Dickson
Leonard Petrucelli
Yong-Jie Zhang
Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
PLoS ONE
title Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
title_full Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
title_fullStr Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
title_full_unstemmed Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
title_short Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43.
title_sort generation and characterization of monoclonal antibodies against pathologically phosphorylated tdp 43
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0298080&type=printable
work_keys_str_mv AT paulacastellanosotero generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT tiffanywtodd generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT weishao generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT carolinejjones generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT kexinhuang generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT lillianmdaughrity generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT meiyue generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT uditsheth generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT taniafgendron generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT mercedesprudencio generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT bjornoskarsson generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT denniswdickson generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT leonardpetrucelli generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43
AT yongjiezhang generationandcharacterizationofmonoclonalantibodiesagainstpathologicallyphosphorylatedtdp43